Nordson Corporation filings document the formal disclosure record for an Ohio precision technology manufacturer with common shares listed on Nasdaq under NDSN. The company’s 8-K reports cover quarterly operating results, Regulation FD earnings commentary, shareholder vote outcomes, capital allocation authorizations, executive officer changes, compensation arrangements, and material financing agreements.
Recent filings include annual meeting results, proxy governance matters, an executive severance policy, a chief accounting officer transition, and an amended senior unsecured multicurrency revolving credit agreement involving Nordson and a German subsidiary. The record also identifies the company’s registered common shares and recurring disclosure areas tied to governance, liquidity, capital structure, and financial reporting.
NORDSON CORP (NDSN) is the issuer for a planned sale of common stock disclosed under Rule 144. The notice relates to securities held for the account of Daniel Roy Hopgood, with Fidelity Brokerage Services LLC acting as broker. The filing indicates an intended sale of 1,329 shares of Nordson common stock, associated with a stock option exercise, with a proposed sale date of August 26, 2026 on NASDAQ. The notice is signed by Jennifer Ruchti as a duly authorized representative of Fidelity, acting as attorney-in-fact for Daniel Hopgood.
Nordson Corporation (NDSN) reported solid growth for the quarter and nine months ended July 31, 2026. Quarterly sales rose to $817.7 million, up 10.3%, with net income of $152.8 million and diluted EPS of $2.73, up 23.0% year over year. Nine-month sales reached $2.23 billion, up 9.2%, while net income grew 21.2% to $403.5 million and diluted EPS increased 23.5% to $7.20. Growth was broad-based, led by the Advanced Technology Solutions segment and strong Asia Pacific demand. Gross margin improved slightly, interest expense declined on lower average debt, and operating cash flow strengthened to $570.5 million, supporting debt reduction, dividends, and share repurchases. Total debt outstanding decreased to about $1.74 billion, with a new $1.2 billion revolving credit facility and a $1.2 billion commercial paper program providing additional liquidity.
Nordson Corporation (NDSN) reported record fiscal third quarter 2026 results, with sales of $817.7 million, up 10% from $741.5 million a year earlier, driven by approximately 12% organic growth across all segments. Net income rose to $152.8 million, and diluted EPS reached a record $2.73 versus $2.22.
Adjusted diluted EPS, excluding acquisition-related items and a non-cash minority investment loss, was a record $3.25, up 19% from $2.73. EBITDA was an all-time quarterly record of $262.5 million, maintaining a 32% margin. Backlog increased 35% year-over-year, reflecting strong demand.
All three segments achieved record or strong sales, led by Advanced Technology Solutions with 28% growth and a 30% EBITDA margin. Nordson raised full-year guidance to sales of $3.04–$3.08 billion and adjusted EPS of $11.80–$12.00 per diluted share. Year-to-date free cash flow was $530.2 million, supporting debt reduction, dividends, and share repurchases.
Nordson Corp director Christopher L. Mapes acquired 42 stock equivalent units on July 31, 2026 by electing to defer a portion of his quarterly cash retainer at $297.78 per unit under the Directors' Deferred Compensation Sub-Plan. At distribution, these units convert to common shares on a one-for-one basis. Following this award, he holds 3,025 stock equivalent units in total, including 8 stock equivalent and/or restricted share units accrued from dividend payments under the Stock Incentive and Award Plan.
DeFord John A reported acquisition or exercise transactions in this Form 4 filing.
Nordson Corp director John A. DeFord elected to defer his quarterly cash retainer, receiving 84 stock equivalent units tied to NDSN common stock at $297.78 per unit on July 31, 2026 under the company's Directors' Deferred Compensation Sub-Plan.
After this award, DeFord directly holds 5,902 shares, including 16 stock equivalent and/or restricted share units accrued from dividend payments.
Nordson Corporation VP and CAO Joseph M. Rutledge reported a tax-withholding disposition of 274 NDSN shares at $297.78 per share on July 31, 2026. The shares were withheld to cover taxes due upon vesting of restricted share units, and Rutledge now holds 2,818 shares directly. A related footnote states that 2,875 restricted share units were awarded on August 1, 2025, vesting in one-third increments over three years.
Nordson Corporation established a new commercial paper program that allows it to issue unsecured short-term notes with up to $1.2 billion outstanding at any time. These notes will be issued on a private placement basis and may be sold at a discount or at par with interest rates set by market conditions on each issue date.
The notes will have varying maturities but cannot exceed 364 days from issuance, and proceeds are intended for general corporate purposes. A national bank serves as issuing and paying agent, and Nordson has entered into substantially identical dealer agreements with multiple commercial paper dealers that include customary representations, covenants and indemnification. The notes are not registered under the Securities Act of 1933 and will only be offered under applicable registration exemptions.
Nordson Corp executive Daniel Roy Hopgood, EVP and CFO, reported a small share disposition related to tax withholding. On the reported date, 148 Nordson shares were withheld at $281.31 per share to cover taxes due when previously granted restricted share units vested. This was an automatic tax-withholding transaction under the company’s stock plan, not an open-market sale, and left Hopgood with 4,758 shares held directly.
Nordson Corporation reported solid growth for the quarter and first half of fiscal 2026. For the three months ended April 30, 2026, sales were $740.8 million, up 8.5% from a year ago, with net income of $117.3 million and diluted EPS of $2.09. Operating profit rose 16.9% as all three segments grew, led by Advanced Technology Solutions and Medical and Fluid Solutions, while gross margin stayed around 55%.
For the first six months, sales reached $1.41 billion, up 8.6%, and net income increased 21.1% to $250.7 million, or $4.47 per diluted share. Interest expense declined on lower average debt, and other income benefited from gains on a minority investment, partly offset by a $24.0 million U.S. pension settlement loss. Operating cash flow was strong at $321.1 million, supporting $107 million of debt repayment, $129.3 million of share repurchases, and $91.6 million of dividends, while maintaining access to a $1.2 billion revolving credit facility.